Spain leads in Rhabdomyosarcoma treatment, with top institutions accredited by the Joint Commission International. Key clinics like Centro Médico Teknon, Quironsalud Madrid, and SJD Barcelona Children’s Hospital offer advanced treatments. Centro Médico Teknon in Barcelona excels in oncology with comprehensive services for international patients. Quironsalud Madrid, the largest in its network, leads in oncology research, offering clinical trials for eligible patients.
SJD Barcelona Children’s Hospital is a top pediatric oncology center in Europe, known for innovative methods from its Laboratory for Molecular Medicine. Spain's Rhabdomyosarcoma survival rate improves with proton beam therapy, stereotactic radiosurgery, molecular targeted therapy, and immunotherapy. Recent clinical trials show promising results in chemotherapy advancements.